BioMap
A life science large model enterprise, officially stating that it has independently developed the xTrimo basic model and the BioMap OS dry-wet closed-loop discovery system, supports data insights and de novo design, and provides discovery services such as antibodies and proteins to pharmaceutical companies and scientific research institutions.
Updated: 2026-10-26
What is BioMap?
BioMap is a pioneer in the field of life science AI foundation models, officially recognized as the world's first developer of large-scale parameter life science foundation models. Its xTrimo model is built on raw biological data, and it is claimed to be able to understand the underlying laws at the levels of DNA, RNA, proteins, cells, chemistry, multicellular organisms and biological systems. It has achieved numerous optimal model performance records in more than twenty fields. On the product side, it delivers the BioMap OS, a wet-dry closed-loop discovery system, to the outside world.
Who is it for?
- Early R&D teams of biopharmaceutical companies: Use the model for target exploration and molecular design to narrow the scope of experimental screening.
- Antibody and protein engineering teams: Leverage de novo design and multi-objective optimization capabilities to enhance the quality of candidate molecules.
- Synthetic biology companies: Link design, prediction and experimental processes into a closed loop to accelerate iteration.
- Universities and research institutions: Leverage the capabilities of foundational models to support cutting-edge biological research.
- R&D directors: Evaluate the costs and timelines of both the licensed usage and commissioned service collaboration models.
Key features
6Life Sciences Foundation Model
The official statement says that xTrimo is modeled on raw biological data and possesses cross-modal reasoning capabilities for complex and previously unknown biological problems.
BioMap OS Discovery System
Officially stated to be model-driven, it integrates functional modules such as knowledge aggregation, predictive design, experimental control and model training into a single system.
Wet-Dry Closed Loop
It is officially stated that it connects the cycle between in silico and wet lab experiments, enabling full-cycle data accumulation and analysis, and improving R&D efficiency and success rates.
Modular Delivery
The company states that the system can be deployed in the form of models, software or complete systems, supporting both cloud and on-premises deployment.
Four major industry solutions
The company states that it provides specialized solutions in four areas: antibodies and proteins, innovative therapeutics and precision medicine, synthetic biology, and cutting-edge scientific research.
Discovery Service Model
The company states that customers can either license the system to independently conduct discovery workflows or entrust the company to provide discovery services for antibodies, proteins, and other related areas.
How to use BioMap
- Conduct a proof-of-concept on a well-defined molecule or target task first, then evaluate whether to scale up to larger-scale projects.
- The effectiveness of the dry-wet closed loop relies on the quality of experimental data, and non-standardized experimental records will significantly reduce the value of the model.
- Clarify the ownership of intellectual property, especially the ownership rights of molecules and data generated by commissioned discovery services, which should be included in the agreement.
- Biological data involves ethical and compliance requirements, and when it comes to human sample data, it is necessary to ensure the completeness of the authorization chain.
- Use model predictions as a screening acceleration tool.
- key candidates must still undergo the complete experimental verification process.
- In addition, the positioning of outputs from health-focused AI is always "aided understanding" rather than a diagnostic conclusion: it can help you translate report indicators and symptom descriptions into easier-to-understand language, but medication, surgery, and treatment plans must be judged by licensed physicians.
- For urgent symptoms, please seek medical attention directly.
Traffic & popularity
Data month Sep 2026
BioMap receives about 29.8K visits per month and ranks #451,447 worldwide.
Monthly visits
12 monthsTraffic sources
- Direct63.9%
- Search26.8%
- Referrals3.2%
- AI assistants2.2%
- Social1.5%
- Other2.4%
Top countries
- China86.0%
- United States14.0%
Estimated from third-party traffic data.
Similar tools
XtalPiAn AI and robotics-driven pharmaceutical R&D platform enterprise, officially stated that it takes Agentic AI as the intelligent hub, uses more than 200 vertical-domain AI models for predictive design, and has laboratory robots complete wet experiments, forming a self-iterative R&D closed loop of dry and wet experiments.
DeepTechAn AI for Science enterprise, officially stating that it takes DeepShine·Yuzhi Scientific Discovery Intelligent Engine as the foundation, builds tools such as Bohr Scientific Navigation and Lebesgue Intelligent Computing and scientific intelligent agents, targeting basic scientific research and drug and material R&D.
Insilico MedicineInsilico Medicine is a clinical-stage biotech company using generative AI for drug discovery. Its platform includes PandaOmics for target identification, with public pipelines covering fibrosis and tumors. The drugs under research have not been marketed yet and should be taken under medical advice.